Itron (NASDAQ:ITRI) Upgraded at Stephens

Stephens upgraded shares of Itron (NASDAQ:ITRI) from an equal weight rating to an overweight rating in a research report sent to investors on Monday morning, MarketBeat.com reports. The brokerage currently has $130.00 price objective on the scientific and technical instruments company’s stock.

ITRI has been the topic of a number of other research reports. Wall Street Zen raised shares of Itron from a “hold” rating to a “buy” rating in a research note on Saturday, November 1st. Oppenheimer set a $145.00 target price on shares of Itron and gave the company an “outperform” rating in a research report on Friday, October 31st. Johnson Rice downgraded shares of Itron from a “buy” rating to an “accumulate” rating in a research report on Friday, August 1st. Baird R W lowered shares of Itron from a “strong-buy” rating to a “hold” rating in a research note on Friday, October 31st. Finally, Roth Capital boosted their price objective on Itron from $130.00 to $150.00 and gave the stock a “buy” rating in a research note on Tuesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $139.00.

Itron Price Performance

Shares of Itron stock opened at $107.15 on Monday. The firm has a market cap of $4.90 billion, a PE ratio of 18.32, a P/E/G ratio of 0.76 and a beta of 1.48. Itron has a twelve month low of $90.11 and a twelve month high of $142.00. The company has a quick ratio of 1.75, a current ratio of 2.04 and a debt-to-equity ratio of 0.48. The business has a 50-day moving average price of $123.64 and a 200 day moving average price of $123.18.

Itron (NASDAQ:ITRI) last issued its quarterly earnings data on Thursday, October 30th. The scientific and technical instruments company reported $1.54 EPS for the quarter, beating the consensus estimate of $1.48 by $0.06. The company had revenue of $581.63 million for the quarter, compared to analyst estimates of $578.49 million. Itron had a return on equity of 19.69% and a net margin of 11.05%.Itron’s quarterly revenue was down 5.5% compared to the same quarter last year. During the same period last year, the company earned $1.84 earnings per share. Itron has set its FY 2025 guidance at 6.840-6.940 EPS. Q4 2025 guidance at 2.150-2.250 EPS. Sell-side analysts predict that Itron will post 5.33 earnings per share for the current fiscal year.

Insider Activity

In other Itron news, SVP John F. Marcolini sold 565 shares of Itron stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $125.31, for a total transaction of $70,800.15. Following the transaction, the senior vice president directly owned 14,396 shares of the company’s stock, valued at $1,803,962.76. The trade was a 3.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Donald L. Reeves III sold 547 shares of the stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $125.31, for a total transaction of $68,544.57. Following the completion of the sale, the senior vice president directly owned 19,604 shares of the company’s stock, valued at approximately $2,456,577.24. This trade represents a 2.71% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 3,037 shares of company stock worth $380,566. Insiders own 1.45% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in ITRI. EverSource Wealth Advisors LLC increased its stake in Itron by 25.3% during the second quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company’s stock worth $53,000 after acquiring an additional 81 shares during the last quarter. Amalgamated Bank grew its stake in shares of Itron by 0.7% in the third quarter. Amalgamated Bank now owns 13,060 shares of the scientific and technical instruments company’s stock worth $1,627,000 after acquiring an additional 86 shares in the last quarter. PFG Investments LLC increased its holdings in Itron by 4.8% during the 3rd quarter. PFG Investments LLC now owns 2,059 shares of the scientific and technical instruments company’s stock worth $256,000 after purchasing an additional 94 shares during the period. Louisiana State Employees Retirement System increased its stake in shares of Itron by 0.5% during the second quarter. Louisiana State Employees Retirement System now owns 21,300 shares of the scientific and technical instruments company’s stock worth $2,804,000 after buying an additional 100 shares during the period. Finally, Elevation Point Wealth Partners LLC increased its position in shares of Itron by 3.5% in the 2nd quarter. Elevation Point Wealth Partners LLC now owns 3,398 shares of the scientific and technical instruments company’s stock valued at $447,000 after purchasing an additional 115 shares during the last quarter. 96.19% of the stock is currently owned by institutional investors and hedge funds.

Itron Company Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.